We are live on
!
Find out more
GENE
Genetic Technologies Ltd.
GENE
GENE
Delisted
GENE was delisted on the 16th of October, 2024.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
1
Renaissance Technologies
New York
| $857K | +$169K | +4,160 | +21% |
|
| 2 |
VKH
2
Virtu KCG Holdings
New York
| $24K | -$2.08K | -51 | -7% |
|
| 3 |
3
Citadel Advisors
Miami,
Florida
| $19K | +$21.7K | +532 | New |
|
| 4 |
4
UBS Group
Zurich,
Switzerland
| $5K | -$15.4K | -379 | -74% |
|
| 5 |
LTFS
5
Ladenburg Thalmann Financial Services
Miami,
Florida
| $5K | – | – | – |
|
| 6 |
6
Morgan Stanley
New York
| $2K | – | – | – |
|
| 7 |
7
Citigroup
New York
| $1K | – | – | – |
|
| 8 |
FANJ
8
Financial Architects (New Jersey)
Marlton,
New Jersey
| $1K | – | – | – |
|
| 9 |
PCM
9
Prelude Capital Management
New York
| $1K | +$611 | +15 | New |
|
| 10 |
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$81 | -2 | -9% |
|
| 11 |
CG
11
Cutler Group
San Francisco,
California
| – | +$1.02K | +25 | New |
|